Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Dhiraj Bhavsar"'
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 119:96-106
Gene silencing has immense potential in the treatment of cancer. However, enhancement of its efficiency requires the development of specifically targeted and safe carrier systems. Cationic carriers are generally limited by their immunogenicity. Hence
Autor:
Narnamangalam R. Jagannathan, Banudevi Sivanantham, Swaminathan Sethuraman, Dhiraj Bhavsar, David Raj Chellappan, Ravi Ranganathan, Uma Sharma, Anuradha Subramanian, L.R. Jaidev, Uma Maheswari Krishnan
Publikováno v:
Acta Biomaterialia. 49:422-433
Theranostics has received considerable attention since both therapy and imaging modalities can be integrated into a single nanocarrier. In this study, fluorescent iron oxide (FIO) nanoparticles and gemcitabine (G) encapsulated poly(lactide-co-glycoli
Publikováno v:
Drug Delivery. 23:2488-2496
Nano-delivery systems have significantly evolved over the last decade for the treatment of cancer by enabling site-specific delivery and improved bioavailability. The widely investigated nanoparticle systems are biodegradable polyesters, dendrimers,
Publikováno v:
Drug delivery. 23(4)
RNA interference (RNAi) technology using short interfering RNA (si-RNA) has shown immense potential in the treatment of cancers through silencing of specific genes. Cationic non-viral vectors employed for gene delivery exhibit toxic effects in normal
Autor:
L.R. Jaidev, N. R. Jagannathan, Dhiraj Bhavsar, Uma Maheswari Krishnan, Swaminathan Sethuraman, Uma Sharma
Publikováno v:
Journal of biomaterials science. Polymer edition. 25(11)
Multifunctional nanoparticles are next generation materials that can be simultaneously used for imaging, diagnosis, and delivery of drugs. However, materials intended for cancer diagnosis need to be investigated for its cell uptake, toxicity, and eff
Publikováno v:
Current gene therapy. 12(4)
Gene silencing has emerged as a promising strategy for molecular therapy of various malignant, viral, hereditary and inflammatory disorders. However, its translation from lab to clinic is yet to gain momentum due to the numerous problems that plague
Autor:
Uma Maheswari Krishnan, Swaminathan Sethuraman, Lakshmi Narashimhan Ramana, Dhiraj Bhavsar, Krishnakumar Subramanian
Publikováno v:
Nano. 10:1550052
Objective: A major limitation in gene delivery applications employing nanocarriers is the inflammatory response elicited when administered in vivo. The mode of complexation of the oligonucleotide with the carrier can alter its interactions with biomo